Shareholder Suit Over GTx And Oncternal Merger Tossed
A New York federal judge on Tuesday dismissed a proposed class action filed against merged biopharmaceutical companies GTx Inc. and Oncternal Therapeutics Inc. that alleged they misrepresented the details of their...To view the full article, register now.
Already a subscriber? Click here to view full article